Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04142619
Title Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectis S.A.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.